ANZOS & Breakthrough Discoveries 2018 Joint ConferenceOctober 16 - 18, 2018 Melbourne Convention & Exhibition Centre

Dr Michelle Keske

Dr Michelle Keske has been working in the type 2 diabetes field for 20 years. This includes her PhD from the University of Tasmania, and 5 years of postdoctoral training at the University of Virginia and the National Institutes of Health in the USA where she studied the vascular effects of insulin on muscle glucose metabolism. Her research implicates the role of impaired vascular function in muscle in the development of insulin resistance. While in the USA she also spent 3 years working in Industry (Martek Biosciences Corp. Maryland, USA) studying the effect of long chain omega 3 fatty acids on diabetes and cardiovascular outcomes. She returned to Tasmania in 2007 after being appointed a Senior Research Fellowship at the Menzies Institute for Medical Research, where she continues her work on muscle blood flow and insulin action. She is the head of the Diabetes group at the Menzies Institute for Medical Research and also serves on the Board of Directors for Diabetes Tasmania.